NeuroMetrix Inc (NeuroMetrix) is a healthcare company. It develops wearable medical technology and point-of-care tests to manage chronic pain, nerve diseases, and sleep disorders. The company’s products include Quell wearable pain relief devices, quell health cloud, DPNCheck point-of-care neuropathy tests, and advanced system. Its DPNCheck is used for the treatment of diabetic peripheral neuropathy. NeuroMetrix offers services in basic and clinical neurophysiology, biomedical engineering and instrumentation, and information technology. The company serves clinics, hospitals, managed care organizations, retail health businesses, and durable medical equipment suppliers. It markets its products through its network of distributors in Americas, Europe, Asia, and the Middle East. NeuroMetrix is headquartered in Waltham, Massachusetts, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company NeuroMetrix Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
- NeuroMetrix Inc Company Overview
- NeuroMetrix Inc Company Snapshot
- NeuroMetrix Inc Pipeline Products and Ongoing Clinical Trials Overview
- NeuroMetrix Inc - Pipeline Analysis Overview
- NeuroMetrix Inc - Key Facts
- NeuroMetrix Inc - Major Products and Services
- NeuroMetrix Inc Pipeline Products by Development Stage
- NeuroMetrix Inc Ongoing Clinical Trials by Trial Status
- NeuroMetrix Inc Pipeline Products Overview
- Andara OFS Plus
- Andara OFS Plus Product Overview
- Andara Oscillating Field Stimulator System
- Andara Oscillating Field Stimulator System Product Overview
- DPN - Fall Prevention
- DPN - Fall Prevention Product Overview
- DPN - Foot Ulcer Healing
- DPN - Foot Ulcer Healing Product Overview
- DPNCheck Cloud
- DPNCheck Cloud Product Overview
- Intra-Operative Peripheral Nerve Assessment And Monitoring Device
- Intra-Operative Peripheral Nerve Assessment And Monitoring Device Product Overview
- NeuroMetrix Navigator
- NeuroMetrix Navigator Product Overview
- Quell - Chronic Low Back Pain
- Quell - Chronic Low Back Pain Product Overview
- Quell - Chronic Overlapping Pain Conditions
- Quell - Chronic Overlapping Pain Conditions Product Overview
- Quell - CIPN
- Quell - CIPN Product Overview
- Quell - CIPN Clinical Trial
- Quell - NMOSD
- Quell - NMOSD Product Overview
- Quell - Post-Acute COVID-19 Syndrome
- Quell - Post-Acute COVID-19 Syndrome Product Overview
- Quell - Restless Leg Syndrome
- Quell - Restless Leg Syndrome Product Overview
- Sensus Assistant
- Sensus Assistant Product Overview
- Sensus RLS
- Sensus RLS Product Overview
- NeuroMetrix Inc - Key Competitors
- NeuroMetrix Inc - Key Employees
- NeuroMetrix Inc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Joint Venture
- Recent Developments
- NeuroMetrix Inc, Recent Developments
- Mar 13, 2024: NeuroMetrix announces that over 2000 patients with fibromyalgia have been prescribed Quell Fibromyalgia
- Dec 12, 2023: NeuroMetrix Reports Encouraging Results from Pilot Clinical Trial of Quell in Post-Acute COVID-19 Syndrome (Long COVID)
- Aug 30, 2023: NeuroMetrix to Present at the Emerging Growth Conference on September 6, 2023
- Jul 11, 2023: Neurometrix Announces Sales Force Expansion for Quell Fibromyalgia
- Jun 28, 2023: Recent Publications Demonstrate Utility of DPNCheck for Identifying High-Risk Diabetes Patients
- Mar 21, 2023: NeuroMetrix to exhibit quell fibromyalgia and present new clinical data at the American Academy of Pain Medicine 2023 Annual Meeting
- Nov 08, 2022: NeuroMetrix to introduce Quell Fibromyalgia at the American College of Rheumatology 2022 Annual Meeting
- Nov 03, 2022: NeuroMetrix announces strategic launch of Quell Fibromyalgia
- Jul 14, 2022: MCRA assists NeuroMetrix with obtaining FDA breakthrough device designation and marketing authorization in one year
- May 19, 2022: NeuroMetrix reports that Quell wearable neuromodulation device has received FDA De Novo authorization as first non-pharmacological treatment for fibromyalgia
- Appendix
- Methodology
- About the Analyst
- Contact the Publisher
- Disclaimer
- NeuroMetrix Inc Pipeline Products and Ongoing Clinical Trials Overview
- NeuroMetrix Inc Pipeline Products by Equipment Type
- NeuroMetrix Inc Pipeline Products by Indication
- NeuroMetrix Inc Ongoing Clinical Trials by Trial Status
- NeuroMetrix Inc, Key Facts
- NeuroMetrix Inc, Major Products and Services
- NeuroMetrix Inc Number of Pipeline Products by Development Stage
- NeuroMetrix Inc Pipeline Products Summary by Development Stage
- NeuroMetrix Inc Ongoing Clinical Trials by Trial Status
- NeuroMetrix Inc Ongoing Clinical Trials Summary
- Andara OFS Plus - Product Status
- Andara OFS Plus - Product Description
- Andara Oscillating Field Stimulator System - Product Status
- Andara Oscillating Field Stimulator System - Product Description
- DPN - Fall Prevention - Product Status
- DPN - Fall Prevention - Product Description
- DPN - Foot Ulcer Healing - Product Status
- DPN - Foot Ulcer Healing - Product Description
- DPNCheck Cloud - Product Status
- DPNCheck Cloud - Product Description
- Intra-Operative Peripheral Nerve Assessment And Monitoring Device - Product Status
- Intra-Operative Peripheral Nerve Assessment And Monitoring Device - Product Description
- NeuroMetrix Navigator - Product Status
- NeuroMetrix Navigator - Product Description
- Quell - Chronic Low Back Pain - Product Status
- Quell - Chronic Low Back Pain - Product Description
- Quell - Chronic Overlapping Pain Conditions - Product Status
- Quell - Chronic Overlapping Pain Conditions - Product Description
- Quell - CIPN - Product Status
- Quell - CIPN - Product Description
- Quell - CIPN - Transcutaneous Electrical Nerve Stimulation for Lower Extremity in Patients With Neurogenic Pain - A Proof Concept Randomized Clinical Trial
- Quell - NMOSD - Product Status
- Quell - NMOSD - Product Description
- Quell - Post-Acute COVID-19 Syndrome - Product Status
- Quell - Post-Acute COVID-19 Syndrome - Product Description
- Quell - Restless Leg Syndrome - Product Status
- Quell - Restless Leg Syndrome - Product Description
- Sensus Assistant - Product Status
- Sensus Assistant - Product Description
- Sensus RLS - Product Status
- Sensus RLS - Product Description
- NeuroMetrix Inc, Key Employees
- NeuroMetrix Inc, Joint Venture
- Glossary
- NeuroMetrix Inc Pipeline Products by Equipment Type
- NeuroMetrix Inc Pipeline Products by Development Stage
- NeuroMetrix Inc Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Spiration Inc
- Nevro Corp
- NeuSpera Medical Inc
- Abbott Laboratories
- Biometrix Inc
